tiprankstipranks
PCVX Earnings this Week: How Will it Perform?
PremiumPre-EarningsPCVX Earnings this Week: How Will it Perform?
20d ago
Vaxcyte management to meet with Cantor Fitzgerald
Premium
The Fly
Vaxcyte management to meet with Cantor Fitzgerald
2M ago
Vaxcyte price target raised to $163 from $113 at Mizuho
Premium
The Fly
Vaxcyte price target raised to $163 from $113 at Mizuho
2M ago
Vaxcyte price target raised to $153 at Leerink after VAX-31 ‘home run’
PremiumThe FlyVaxcyte price target raised to $153 at Leerink after VAX-31 ‘home run’
3M ago
Needham ups Vaxcyte target to $140 after ‘best-case scenario’ data
Premium
The Fly
Needham ups Vaxcyte target to $140 after ‘best-case scenario’ data
3M ago
Vaxcyte price target raised to $140 from $95 at Needham
Premium
The Fly
Vaxcyte price target raised to $140 from $95 at Needham
3M ago
Vaxcyte reports data from study of VAX-31 vaccine candidate in adults 50+
PremiumThe FlyVaxcyte reports data from study of VAX-31 vaccine candidate in adults 50+
3M ago
Vaxcyte reports Q2 EPS ($1.10), consensus (98c)
Premium
The Fly
Vaxcyte reports Q2 EPS ($1.10), consensus (98c)
4M ago
Vaxcyte Appoints John Furey as New Independent Board Director
Premium
Company Announcements
Vaxcyte Appoints John Furey as New Independent Board Director
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100